Jasgit C Sachdev (Jasgit Sachdev)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Metastatic Breast Cancer

Locally Advanced

Tyrosine Kinase

Advanced Non Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Investigational new drugs

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Gerald S Falchook, Jasgit C Sachdev, Esteban Rodrigo Imedio, Sanjeev Kumar, Ganesh M Mugundu, Suzanne Jenkins, Juliann Chmielecki, Suzanne F Jones, David R Spigel, Melissa Lynne Johnson
A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumors. Investigational new drugs (2023)
Pamela N Munster, Andrew E Greenstein, Gini F Fleming, Erkut Hasan Borazanci, Manish R Sharma, Joseph M Custodio, Iulia Cristina Tudor, Hristina I Pashova, Stacie Peacock Shepherd, Andreas Grauer, Jasgit C Sachdev
Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (15) (2022)
Michael L Maitland, Jasgit C Sachdev, Manish R Sharma, Victor Moreno, Valentina Boni, Shivaani Kummar, Erica Stringer-Reasor, Nehal Lakhani, Allison R Moreau, Dawei Xuan, Ray Li, Eric L Powell, Amy Jackson-Fisher, Michelle Bowers, Shilpa Alekar, Xiaohua Xin, Anthony W Tolcher, Emiliano Calvo
First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody-Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (16) (2021)
Jasgit C Sachdev, Pamela Munster, Donald W Northfelt, Hyo Sook Han, Cynthia Ma, Fiona Maxwell, Tiffany Wang, Bruce Belanger, Bin Zhang, Yan Moore, Arunthathi Thiagalingam, Carey Anders
Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase. Breast cancer research and treatment 185 (3) (2020)
Komal Jhaveri, Matthew T Chang, Dejan Juric, Cristina Saura, Valentina Gambardella, Anton Melnyk, Manish R Patel, Vincent Ribrag, Cynthia X Ma, Raid Aljumaily, Philippe L Bedard, Jasgit C Sachdev, Lara Dunn, Helen H Won, John Bond, Surai Jones, Heidi M Savage, Maurizio Scaltriti, Timothy R Wilson, Michael C Wei, David M Hyman
Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)